Skip to content

Dr. MJB

Active
Private limited companyfounded 20241 yr activePalepelstraat 12, 9830 Sint-Martens-Latem, BelgiumKBO/BCE: BE 1014.894.865
Summary

Dr. MJB has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €69,418 and a net result of €66,418. The computed 12-month bankruptcy probability is 1.5% (low).

Checked score

Score 2025
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
1.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5,000 at 30 days acceptable
Liquidity ample (current ratio 7.32; short-term debt: 13.5% and cash: 79.1% of total assets), and 14.6% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
85.4%
Return on assets
81.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
3 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 9 October 2024, Dr. MJB was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€69,418
Total assets
€81,298
Net result
€66,418
Working capital
€69,511

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €81,298
Fixed assets €785
Current assets €80,513
Equity and liabilities €81,298
Equity €69,418
Debt €11,880
Debt finances 14.6% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€86,750
Cash flow
€68,684
Current ratio
7.32
Debt to equity
0.17
ROE
95.7%
ROA
81.7%
Interest coverage
1078.57
Debt ≤ 1 year
€11,002
Income taxes
€17,996
Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 39 lines
Balance sheet Code2025
Assets
Total assets20/58€81,298
Fixed assets21/28€785
Tangible fixed assets22/27€785
Furniture and vehicles24€785
Current assets29/58€80,513
Amounts receivable within one year40/41€1,047
Trade receivables40€262
Other amounts receivable41€785
Current investments50/53€1,965
Cash at bank and in hand54/58€64,345
Deferred charges and accrued income490/1€13,157
Equity and liabilities
Total equity and liabilities10/49€81,298
Equity10/15€69,418
Contributions10/11€3,000
Reserves13€66,418
Distributable reserves133€66,418
Amounts payable17/49€11,880
Amounts payable within one year42/48€11,002
Trade debts44€1,009
Suppliers440/4€1,009
Taxes, remuneration and social security45€9,993
Taxes450/3€7,493
Remuneration and social security454/9€2,500
Accrued charges and deferred income492/3€878
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,266
Other operating charges640/8€110
Gross operating margin9900€86,860
Operating profit (loss)9901€84,484
Financial income75/76B€11
Recurring financial income75€11
Financial charges65/66B€80
Recurring financial charges65€80
Profit (loss) for the period before taxes9903€84,414
Income taxes67/77€17,996
Profit (loss) for the period9904€66,418
Profit (loss) for the period to be appropriated9905€66,418
Appropriation of the result
Profit (loss) to be appropriated9906€66,418
Transfer to equity691/2€66,418
To other reserves6921€66,418

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,266
Other operating charges640/8€110
Gross operating margin9900€86,860
Operating profit (loss)9901€84,484
Financial income75/76B€11
Recurring financial income75€11
Financial charges65/66B€80
Recurring financial charges65€80
Profit (loss) for the period before taxes9903€84,414
Income taxes67/77€17,996
Profit (loss) for the period9904€66,418
Profit (loss) for the period to be appropriated9905€66,418
Line2025
Assets
Total assets20/58€81,298
Fixed assets21/28€785
Tangible fixed assets22/27€785
Furniture and vehicles24€785
Current assets29/58€80,513
Amounts receivable within one year40/41€1,047
Trade receivables40€262
Other amounts receivable41€785
Current investments50/53€1,965
Cash at bank and in hand54/58€64,345
Deferred charges and accrued income490/1€13,157
Equity and liabilities
Total equity and liabilities10/49€81,298
Equity10/15€69,418
Contributions10/11€3,000
Reserves13€66,418
Distributable reserves133€66,418
Amounts payable17/49€11,880
Amounts payable within one year42/48€11,002
Trade debts44€1,009
Suppliers440/4€1,009
Taxes, remuneration and social security45€9,993
Taxes450/3€7,493
Remuneration and social security454/9€2,500
Accrued charges and deferred income492/3€878
Line2025
Profit (loss) for the period9904€66,418
+ Depreciation and write-downs630€2,266
Operating cash flow (approximation)€68,684

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
28-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Martens-Latem · 1 establishment unit since 2024
seat establishment approximate The establishment unit on the map
Ground area
1,287 m²
Building footprint
143 m²
Volume, LiDAR
849 m³
Parcel 44064B0491/00P000, Flanders · tallest building 10.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Palepelstraat 12 A, 9830 Sint-Martens-Latem
General medical practice
since 20242.365.413.591
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44064B0491/00P000 Flanders 1,287 m² 1 · 143 m² 10.1 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded09-10-2024
Fiscal year end31-12

Scores and ratios are computed by Checked and are not a credit decision.